These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 18954995)
1. Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs. Camps P; Duque MD; Vázquez S; Naesens L; De Clercq E; Sureda FX; López-Querol M; Camins A; Pallàs M; Prathalingam SR; Kelly JM; Romero V; Ivorra D; Cortés D Bioorg Med Chem; 2008 Dec; 16(23):9925-36. PubMed ID: 18954995 [TBL] [Abstract][Full Text] [Related]
2. Stereoselective synthesis and pharmacological evaluation of [4.3.3]propellan-8-amines as analogs of adamantanamines. Torres-Gómez H; Lehmkuhl K; Frehland B; Daniliuc C; Schepmann D; Ehrhardt C; Wünsch B Bioorg Med Chem; 2015 Aug; 23(15):4277-4285. PubMed ID: 26145819 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines. Duque MD; Camps P; Profire L; Montaner S; Vázquez S; Sureda FX; Mallol J; López-Querol M; Naesens L; De Clercq E; Prathalingam SR; Kelly JM Bioorg Med Chem; 2009 Apr; 17(8):3198-206. PubMed ID: 19251424 [TBL] [Abstract][Full Text] [Related]
4. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine]. Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040 [TBL] [Abstract][Full Text] [Related]
5. Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds. Torres E; Duque MD; Vanderlinden E; Ma C; Pinto LH; Camps P; Froeyen M; Vázquez S; Naesens L Antiviral Res; 2013 Sep; 99(3):281-91. PubMed ID: 23800838 [TBL] [Abstract][Full Text] [Related]
6. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities. Torres E; Duque MD; López-Querol M; Taylor MC; Naesens L; Ma C; Pinto LH; Sureda FX; Kelly JM; Vázquez S Bioorg Med Chem; 2012 Jan; 20(2):942-8. PubMed ID: 22178660 [TBL] [Abstract][Full Text] [Related]
8. Antiviral agents derived from novel 1-adamantyl singlet nitrenes. Kesel AJ; Weiss HC; Schönleber A; Day CW; Barnard DL; Detorio MA; Schinazi RF Antivir Chem Chemother; 2012 Dec; 23(3):113-28. PubMed ID: 23234699 [TBL] [Abstract][Full Text] [Related]
9. The relative potencies of anti-influenza compounds. Tisdale M; Bauer DJ Ann N Y Acad Sci; 1977 Mar; 284():254-63. PubMed ID: 280137 [TBL] [Abstract][Full Text] [Related]
10. Understanding the mechanism of action of the anti-influenza virus drug amantadine. Pinto LH; Lamb RA Trends Microbiol; 1995 Jul; 3(7):271. PubMed ID: 7551640 [No Abstract] [Full Text] [Related]
11. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7. Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015 [TBL] [Abstract][Full Text] [Related]
12. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033 [TBL] [Abstract][Full Text] [Related]
14. Long-term stability of the anti-influenza A compounds--amantadine and rimantadine. Scholtissek C; Webster RG Antiviral Res; 1998 Jun; 38(3):213-5. PubMed ID: 9754890 [TBL] [Abstract][Full Text] [Related]
15. Are the 2-isomers of the drug rimantadine active anti-influenza A agents? Zoidis G; Kolocouris N; Foscolos GB; Kolocouris A; Fytas G; Karayannis P; Padalko E; Neyts J; De Clercq E Antivir Chem Chemother; 2003 May; 14(3):153-64. PubMed ID: 14521332 [TBL] [Abstract][Full Text] [Related]
16. Amantadine-resistant influenza A virus in Taiwan. Shih SR; Lee CN; Tsai HR; Chen GW; Tsao KC J Formos Med Assoc; 2001 Sep; 100(9):608-12. PubMed ID: 11695276 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of bioactive 1,2-annulated adamantane derivatives. Zoidis G; Tsotinis A; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E Org Biomol Chem; 2008 Sep; 6(17):3177-85. PubMed ID: 18698478 [TBL] [Abstract][Full Text] [Related]
18. Amantadine may be lifesaving in severe influenza A. Cunha BA Clin Infect Dis; 2006 Nov; 43(10):1372-3. PubMed ID: 17051511 [No Abstract] [Full Text] [Related]
19. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696 [TBL] [Abstract][Full Text] [Related]